Clinical Trial Update: Infliximab Efficacy, TDM and Serum TNFα Levels in Pediatric HSCT Recipients With aGVHD: Prospective Observational Study

View source ↗

Summary

A completed prospective observational study in pediatric hematopoietic stem cell transplant recipients with acute graft-versus-host disease evaluating the effic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: University of Pisa | Conditions: Graft Versus Host Disease, Acute, Hematopoietic Stem Cell Transplantation | Status: COMPLETED